Gartner publishes complete list of Cool Vendors 2013
Each year, Gartner identifies new Cool Vendors in key technology areas and publishes a series of research reports highlighting these innovative vendors and their products and services. Five Swiss start-ups are on the list: Dacuda, Kooaba, Actlight, Crossing-Tech and CloudSigma.
Three Swiss start-ups had already announced that they are one of the Gartner Cool Vendors 2013: Dacuda, Kooaba and Actlight. Now Gartner has published the complete list. And with Crossing Tech and Eurocloud Swiss are two other Swiss start-ups on the list too.
Crossing-Tech SA, a company held by James Nauffray, founder and CEO, is specialized in solving the critical problem of data inconsistency among incompatible systems. Founded in 2003, Crossing-Tech is especially dedicated for banks and financial institutions facing unprecedented business and technology complexity. Thanks to Crossing-Tech’s product suite Connectivity Factory those institutions can now integrate systems in a matter of days. Crossing-Tech was named Cool Vendor in Application and Integration Platforms.
CloudSigma, founded in 2009, is an innovative Infrastructure-as-a-Service (IaaS) provider based in Zurich, Switzerland. CloudSigma was founded to meet the growing need for a pure IaaS that places little or no restrictions on how its users deploy their computing resources. CloudSigma was named Cool Vendor in the European Cloud Computing Market.
Swiss start-up turns to the Nasdaq
Last year Auris Medical raised more than CHF47 million in venture capital for further growth. This was the largest round of financing in Switzerland in 2013. The company has two drugs in development: an injection for tinnitus and a drug for hearing loss in the inner ear. The tinnitus medication has already started the third and most expensive stage of development, the phase III trial. The Basel company, which has its headquarters in Zug, intends to raise the necessary capital on the Nasdaq: the IPO should bring Auris a total of $95 million in new money.